Safety, Pharmacokinetics, and Efficacy of Bepotastine Besilate Nasal Product After Ragweed Pollen Exposure in an Environmental Chamber

NCT01222299 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG: bepotastine besilate nasal product - low dose
DRUG: bepotastine besilate nasal product - medium dose
DRUG: bepotastine besilate nasal product - high dose
DRUG: placebo comparator nasal product

Sponsor

Bausch & Lomb Incorporated